Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Acetrizoate sodium [USP]
RN: 129-63-5
UNII: 5GF4B2I1DD
InChIKey: UCPVOMHRDXMAIZ-UHFFFAOYSA-M

Note

  • An iodinated radiographic contrast medium used as acetrizoate sodium in HYSTEROSALPINGOGRAPHY.

Classification Code

  • Drug / Therapeutic Agent

Molecular Formulas

  • C9-H5-I3-N-Na-O3
  • C9-H5-I3-N-O3.Na
  • C9-H6-I3-N-O3.Na

Molecular Weight

  • 578.8325
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Acetrizoate sodium
  • Acetrizoate sodium [USP]
  • Sodium acetrizoate [INN]

Synonyms

  • 2,4,6-Trijod-3-acetaminobenzosaeure natrium
  • 2,4,6-Trijod-3-acetaminobenzosaeure natrium [German]
  • 3-Acetamido-2,4,6-triiodobenzoic acid sodium salt
  • Acetrizoate de sodium
  • Acetrizoate de sodium [INN-French]
  • Acetrizoate sodium
  • Acetrizoato sodico
  • Acetrizoato sodico [DCIT]
  • Acetrizoic acid sodium salt
  • Acidum acetrizoicum
  • Bronchoselectan
  • Cystokon
  • Diaginol
  • EINECS 204-956-1
  • Fortombrine-N
  • Iodopact
  • Iodopaque
  • Jodopax
  • MP 1023
  • Natrii acetrizoas
  • Natrii acetrizoas [INN-Latin]
  • Pyelokon-R
  • Reopak
  • Salpix
  • Sodium 3-acetamido-2,4,6-triiodobenzoate
  • Sodium 3-acetylamino-2,4,6-triiodobenzoate
  • Sodium acetrizoate
  • Sodium urokon
  • Thixokon
  • Tri-abrodil
  • Triiodyl
  • Triiotrast
  • Triopac
  • Triopac 200
  • Triopas
  • Triumbren
  • Triurol
  • Triuropan
  • UNII-5GF4B2I1DD
  • Urokon Sodium
  • Vesamin

Systematic Names

  • Benzoic acid, 3-(acetamido)-2,4,6-triiodo-, monosodium salt
  • Benzoic acid, 3-acetamido-2,4,6-triiodo-, monosodium salt
  • Sodium 3-acetamido-2,4,6-triiodobenzoate
  • Sodium acetrizoate

Registry Numbers

CAS Registry Number

  • 129-63-5

FDA UNII

  • 5GF4B2I1DD

System Generated Number

  • 0000129635

Molecular Formulas

Molecular Formulas

  • C9-H5-I3-N-Na-O3
  • C9-H5-I3-N-O3.Na
  • C9-H6-I3-N-O3.Na

Molecular Formula Fragments

  • C9-H5-I3-N-O3
  • C9-H6-I3-N-O3
  • COMPONENT
  • Na

Structure Descriptors

InChI

1S/C9H6I3NO3.Na/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16;/h2H,1H3,(H,13,14)(H,15,16);/q;+1/p-1

InChIKey

UCPVOMHRDXMAIZ-UHFFFAOYSA-M

Smiles

c1(c(c(c(I)cc1I)C(=O)[O-])I)NC(C)=O.[Na+]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 intravenous 5600mg/kg (5600mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Journal of Pharmacology and Experimental Therapeutics. Vol. 116, Pg. 394, 1956.
dog LD50 intravenous 6300mg/kg (6300mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: NAUSEA OR VOMITING
Journal of Pharmacology and Experimental Therapeutics. Vol. 116, Pg. 394, 1956.
mammal (species unspecified) LD50 intravenous 6gm/kg (6000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965.
mouse LD50 intramuscular 12156mg/kg (12156mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 117, Pg. 307, 1956.
mouse LD50 intravenous 7800mg/kg (7800mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 116, Pg. 394, 1956.
rabbit LD50 intravenous 5200mg/kg (5200mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 116, Pg. 394, 1956.
rat LD50 intravenous 6400mg/kg (6400mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 116, Pg. 394, 1956.

Physical Properties

Physical Property Value Units Temp (deg C) Source
log P (octanol-water) 2.260 (none)   EST
Water Solubility 9.42E+05 mg/L 25 EXP
Atmospheric OH Rate Constant 7.30E-13 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.